Page 127 - Immunization Practices News Today

As RSV spreads across the US, many are wondering: Is there a vaccine for RSV? Here, a health expert details new RSV vaccines and preventative treatment.

The vaccine proved more effective than in previous seasons at preventing hospitalizations and emergency room visits.

According to the CDC, the flu shot provided "substantial protection" for all age groups, including elderly and immunocompromised populations, during this influenza season.

The flu shot provided “substantial protection” for all age groups, including elderly and immunocompromised populations, during this influenza season, the Center for Disease Control reported Wednesday.

The ACIP Child and Adolescent Immunization Schedule has been updated for 2023 and published as a schedule and as a policy statement.

On Friday, CDC’s Advisory Committee on Immunization Practices (ACIP) met to discuss the current and future landscape of COVID-19 vaccines. There were no recommendation updates resulting from the meeting, however, the conversations laid the groundwork for future decision-making in the coming months. The ACIP members agreed with the previous FDA sentiment to harmonize COVID-19 vaccine formulations and simplify recommendations for this fall.

Advisers will consider the latest data on the safety and efficacy of mpox vaccinations, updates on the flu season and vaccination and pneumococcal vaccines.

CDC experts on Thursday will discuss two RSV vaccines for babies, older adults and pregnant people as well as an antibody treatment.

The 2022-2023 flu shot reduced the risk of flu-related hospitalization by nearly three quarters among children andby nearly half among adults, according to new data from the US Centers for

The complete primary series monovalent mRNA vaccines protect children aged three to five against symptomatic infection for up to four months.